Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (4): 521-523    DOI: 10.12891/ceog4095.2017
Original Research Previous articles | Next articles
Phytoestrogens for menopausal vasomotor symptoms: efficacy of soybean isoflavones supplements for alleviating menopausal symptoms is positively related to hot flushes frequency
G. Mainini1, *(), M. Passaro2, R. Sgambato3, M. Rotondi4, L. Stradella5, D. Labriola5, D. Ambrosio5, C. Stradella5, M.T. Schettino5, M. Torella5
1 Department of Gynaecology and Obstetrics, S. Leonardo Hospital, Castellammare di Stabia, Naples
2 ASL Napoli 3 Sud, Naples, Child and of General and Specialized Surgery, Second University of Studies of Naples, Naples, Italy
3 ASL Napoli 2 Nord, Naples, Child and of General and Specialized Surgery, Second University of Studies of Naples, Naples, Italy
4 ASL Salerno, Salerno, Child and of General and Specialized Surgery, Second University of Studies of Naples, Naples, Italy
5 Department of Woman, Child and of General and Specialized Surgery, Second University of Studies of Naples, Naples, Italy
Download:  PDF(73KB)  ( 95 )
Export:  BibTeX | EndNote (RIS)      
Abstract  Purpose of investigation: This study was designed to measure the beneficial effects of a combination of nutraceutics containing soy isoflavones (80 mg) and to evaluate the effect of soy isoflavones on hot flushes (HF) and quality of life in a clinical setting, as the authors conducted an observational study. Materials and Methods: This study was conducted on 92 patients with complaints of hot flashes, divided into two groups of 46 each. Group 1 received no therapy and group 2 received 80 mg of isoflavones daily for six months. The patients were interviewed to calculate hot flashes, global and depression scores and were rescored after 2, 4, 8, 12 and 24 weeks. The primary outcome measure was a change in the HF score from baseline. Results: A total of 92 patients, 46 (50%) in the treated group and 46 (50%) in the untreated group, entered the study. Extracts containing high levels of genistein (a substance derived from soy) appeared to reduce the number of daily HF and need to be investigated further. No indication suggested that discrepant results were due to the amount of isoflavones in the active treatment arm, the severity of vasomotor symptoms or trial quality factors. Also, no evidence indicated that these treatments caused oestrogenic stimulation of the endometrium or of the vagina or other adverse effects when used for up to one year. Conclusions: This observational trial suggests a possible beneficial effect of a dietary soy supplement containing 80 mg of isoflavones/day in the management of menopausal symptoms such as HF.
Key words:  Neurovegetative symptoms      Menopause      Isoflavones     
Published:  10 August 2017     
*Corresponding Author(s):  G. MAININI     E-mail:  giampaolomainini@libero.it

Cite this article: 

G. Mainini, M. Passaro, R. Sgambato, M. Rotondi, L. Stradella, D. Labriola, D. Ambrosio, C. Stradella, M.T. Schettino, M. Torella. Phytoestrogens for menopausal vasomotor symptoms: efficacy of soybean isoflavones supplements for alleviating menopausal symptoms is positively related to hot flushes frequency. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 521-523.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4095.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I4/521

[1] Sonia Sánchez, Laura Baquedano, Nicolás Mendoza. Treatment of vulvar pain caused by atrophy: a systematic review of clinical studies[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 800-805.
[2] Gonca Özten Dere, Esra Uyanik, Fatih Aktoz, Pınar Çalış, Sezcan Mümüşoğlu, Hakan Yarali, Gürkan Bozdağ. The effect of laparoscopic ovarian drilling on timing of menopause in patients with polycystic ovary syndrome: 29 years of follow-up data[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 590-593.
[3] R. Tachibana, H. Matsushita, A. Minami, N. Morita, S. Shimizu, H. Kanazawa, T. Suzuki, K. Watanabe, A. Wakatsuki. Dietary sesame diminishes bone mass and bone formation indices in ovariectomized rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 546-551.
[4] F. N. Tuysuzoglu, G. A. Ilhan, B. Yildizhan. The impact of surgical menopause on metabolic syndrome, bone mineral density, and vasomotor symptoms[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 179-182.
[5] N. Morita, H. Matsushita, A. Minami, S. Shimizu, R. Tachibana, H. Kanazawa, T. Suzuki, K. Watanabe, A. Wakatsuki. Effect of the methanol extract of the Lion’s Mane mushroom, Hericium erinaceus, on bone metabolism in ovariectomized rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 47-52.
[6] J.D. Jaremek, D.R. Chinniah, A. Słopień, P. Rynio, R. Słopień. Menopausal depression - state of art[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 859-861.
[7] Lingping Zhu, Xing Chen, Wenpei Bai, Xiaoyan Yan. Factors associated with the quality of life in women with perimenopausal and postmenopausal status: a cross-sectional questionnaire survey from China[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 90-103.
[8] R. Zivadinovic, B. Zivadinovic, A. Petric, D. Krtinic, S.P. Trajkovic Dinic. Medical treatment as a possible treating modality for premalignant vulvar lesions[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 113-117.
[9] Jung Yeob Seoung, Suk Woo Lee, Young Mo Kang, Min Jung Kim, Jae Min Park, Hye Min Moon, Chae Chun Rhim. Association between metabolic risks and bone mineral density in postmenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 671-676.
[10] R. Słopień, S. Khadka, M. Englert-Golon, M. Pisarska-Krawczyk, S. Sajdak. Is there a place for menopausal hormonal therapy in the treatment of postmenopausal osteoporosis?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 325-327.
[11] Ju-Qi Ma, Chun-Fen Guo, Ayshamgul Hasim. Clinical efficacy of levonorgestrel releasing intrauterine system for the treatment of adenomyosis in perimenopausal women[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 387-390.
[12] Y.J. Lee, K.Y. Yun, S.C. Kim, J.K. Joo, K.S. Lee. The association between cystatin C and metabolic syndrome according to menopausal status in healthy Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 716-720.
[13] J. Brodowski, A. Jurczak, E. Grochans, B. Karakiewicz, M. Laszczyńska, S. Ciećwież, A. Włoszczak-Szubzda, A. Starczewski, A. Brodowska. Occurrence of climacteric symptoms in postmenopausal women after prophylactic bilateral ovariectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 403-407.
[14] M.M. Ianieri, D.I.P. Buca, P. Panaccio, M. Cieri, F. Francomano, M. Liberati. Retroperitoneal endometriosis in postmenopausal woman causing deep vein thrombosis: case report and review of the literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 148-150.
[15] S. Mihajlovic, M. Vasiljevic, A. Jurisic, D. Kisic-Tepavcevic, D. Dimitrijevic, L. Nejkovic. Predictive value of transvaginal ultrasound score for detection of endometrial malignancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(5): 698-702.
No Suggested Reading articles found!